Access keys

Skip to content Accessibility Home News, events and publications Site map Search Privacy policy Help Contact us Terms of use

BBSRC Business

Connecting our science with industry, policy makers and society

Summer 2016

Research links heart disease with testosterone

Copyright: Thinkstock
News from: British Heart Foundation
News from: The University of Edinburgh

Testosterone might be involved in explaining why men have a greater risk of heart attacks than women of similar age, according to a study funded by the British Heart Foundation (BHF) and the Biotechnology and Biological Sciences Research Council (BBSRC). The findings, published in the journal Scientific Reports, could lead to new therapies to help reduce heart attack risk.

Each year in the UK 188,000 people visit hospital whilst suffering from a heart attack, which is one person every three minutes.

Scientists at the University of Edinburgh examined the effects of testosterone on blood vessel tissue from mice. They found that the hormone triggers cells from the blood vessels to produce bone-like deposits – a process called calcification.

When the mouse cells were modified, by removing the testosterone receptor, so they could no longer respond to testosterone, they produced far less of the calcium deposits.

The team also looked at blood vessel and valve tissue from people with heart disease who had undergone surgery for their condition. They found that cells from these tissues contained bone-like deposits and also carried the testosterone receptor on their surface. This suggests that testosterone may trigger calcification in people.

Calcification causes blood vessels to harden and thicken, which means the heart has to work harder to pump blood around the body. It is strongly linked to increased risk of heart attack and stroke. Calcification can also affect the heart’s valves, meaning that the valves cannot open and shut properly and may need to be replaced.

Little is known about what triggers calcification and there are currently no treatments. The research team now hope to drill down into the exact mechanism behind this process.

Although naturally occurring, testosterone is also used to counteract low levels of natural testosterone production in a treatment known as androgen replacement therapy. Synthetic substances similar to testosterone are also sometimes misused by athletes in order to enhance athletic performance.

Dr Vicky MacRae, of The University of Edinburgh’s The Roslin Institute, said: “Calcification is particularly difficult to treat, as the biological processes behind the disease are similar to those used by our body to make and repair bone. By finding this link between testosterone and calcification we may have discovered a new way of treating this disease and also reducing heart disease.”

Professor Jeremy Pearson, Associate Medical Director at the British Heart Foundation, which helped fund the research, said: “The role of male sex hormones in the control of vascular calcification is poorly understood. This study, in cells taken from mice and human tissue, provides new evidence that testosterone can increase calcification. But significantly more research is needed to understand whether the results have implications for patients with heart disease or those taking androgen replacement therapy.”

Professor Melanie Welham, BBSRC Chief Executive, said: “This research provides key insights into the bioscience underpinning health. The findings could help develop therapies to reduce the risk factors associated with heart disease, for healthy longer lives.”

ENDS

Notes to editors

Reference: Ablation of the androgen receptor from vascular smooth muscle cells demonstrates a role for testosterone in vascular calcification. Dongxing Zhu et al. Scientific Reports, 2016; 6: 24807.

Find out more about heart attacks and the BHF’s research into improving treatments at www.bhf.org.uk/doubtkills.

To request interviews or for more information please call the BHF press office, tel: +44 2075 540164 or email: newsdesk@bhf.org.uk.

About the British Heart Foundation (BHF)

For over 50 years we’ve pioneered research that’s transformed the lives of people living with heart and circulatory conditions. Our work has been central to the discoveries of vital treatments that are changing the fight against heart disease. But so many people still need our help. From babies born with life-threatening heart problems to the many Mums, Dads and Grandparents who survive a heart attack and endure the daily battles of heart failure. Every pound raised, minute of your time and donation to our shops will help make a difference to people’s lives. For more information, visit www.bhf.org.uk.

About BBSRC

BBSRC invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.

Funded by Government, BBSRC invested over £509M in world-class bioscience in 2014-15. We support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.

For more information about BBSRC, our science and our impact see: www.bbsrc.ac.uk.
For more information about BBSRC strategically funded institutes see: www.bbsrc.ac.uk/institutes.